Recurrent Thyroid Cancer Completed Phase 1 Trials for Paclitaxel (DB01229)

Also known as: Thyroid cancer recurrent

IndicationStatusPhase
DBCOND0028815 (Recurrent Thyroid Cancer)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00004074Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/NeuTreatment